These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 30809494)
1. Navigated laser in diabetic macular edema: the impact of reduced injection burden on patients and physicians-who wins and who loses? Menzler J; Neubauer A; Ziemssen F Int J Ophthalmol; 2019; 12(2):342-345. PubMed ID: 30809494 [TBL] [Abstract][Full Text] [Related]
2. Navigated Laser Therapy for Diabetic Macular Oedema. Kernt M; Ulbig M; Kampik A; Neubauer AS Eur Endocrinol; 2014 Feb; 10(1):66-69. PubMed ID: 29872466 [TBL] [Abstract][Full Text] [Related]
3. 3-year-data of combined navigated laser photocoagulation (Navilas) and intravitreal ranibizumab compared to ranibizumab monotherapy in DME patients. Herold TR; Langer J; Vounotrypidis E; Kernt M; Liegl R; Priglinger SG PLoS One; 2018; 13(8):e0202483. PubMed ID: 30138384 [TBL] [Abstract][Full Text] [Related]
4. Indocyanine green angiography-guided focal navigated laser photocoagulation for diabetic macular edema. Nozaki M; Kato A; Yasukawa T; Suzuki K; Yoshida M; Ogura Y Jpn J Ophthalmol; 2019 May; 63(3):243-254. PubMed ID: 30806869 [TBL] [Abstract][Full Text] [Related]
5. Pain and accuracy of focal laser treatment for diabetic macular edema using a retinal navigated laser (Navilas). Kernt M; Cheuteu RE; Cserhati S; Seidensticker F; Liegl RG; Lang J; Haritoglou C; Kampik A; Ulbig MW; Neubauer AS Clin Ophthalmol; 2012; 6():289-96. PubMed ID: 22393280 [TBL] [Abstract][Full Text] [Related]
6. Effect of Intravitreal Anti-Vascular Growth Factor Agents With or Without Macular Photocoagulation on Diabetic Macular Edema: A Systematic Review and Meta-Analysis. Cui L; Jiao B; Han Q Diabetes Ther; 2019 Aug; 10(4):1283-1296. PubMed ID: 31079358 [TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema. Liegl R; Langer J; Seidensticker F; Reznicek L; Haritoglou C; Ulbig MW; Neubauer AS; Kampik A; Kernt M PLoS One; 2014; 9(12):e113981. PubMed ID: 25541960 [TBL] [Abstract][Full Text] [Related]
8. Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice. Maloney MH; Schilz SR; Herrin J; Sangaralingham LR; Shah ND; Barkmeier AJ Ophthalmology; 2019 Jul; 126(7):1007-1015. PubMed ID: 30292542 [TBL] [Abstract][Full Text] [Related]
9. The impact of anti-vascular endothelial growth factor agents on visual impairment/blindness prevention in patients with diabetic macular edema and on associated patient and caregiver burden in Japan. Kitano S; Sakamoto T; Goto R; Fukushima A; Vataire AL; Hikichi Y J Med Econ; 2019 Mar; 22(3):254-265. PubMed ID: 30550375 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program. Do DV; Nguyen QD; Vitti R; Berliner AJ; Gibson A; Saroj N; Soo Y; Boyer DS Ophthalmology; 2016 Apr; 123(4):850-7. PubMed ID: 26832658 [TBL] [Abstract][Full Text] [Related]
13. Combination of Navigated Macular Laser Photocoagulation and Anti-VEGF Therapy: Precise Treatment for Macular Edema under Dry Retinal Conditions. Boiko EV; Maltsev DS J Ophthalmol; 2017; 2017():7656418. PubMed ID: 28316837 [No Abstract] [Full Text] [Related]
14. Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists. Ogura Y; Shiraga F; Terasaki H; Ohji M; Ishida S; Sakamoto T; Hirakata A; Ishibashi T Jpn J Ophthalmol; 2017 Jan; 61(1):43-50. PubMed ID: 27722786 [TBL] [Abstract][Full Text] [Related]
15. How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular edema? Blindbaek SL; Peto T; Grauslund J Acta Ophthalmol; 2019 Jun; 97(4):339-346. PubMed ID: 30575304 [TBL] [Abstract][Full Text] [Related]
16. Adherence to Intravitreal Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Drugs in Diabetic Macular Edema in an Egyptian Population: A Health Belief Model. Habib AE; Abdel-Kader AA; Eissa IM; Awadein A Curr Eye Res; 2019 Mar; 44(3):303-310. PubMed ID: 30383436 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Novel, Non Contact, Automated Focal Laser with Integrated (NAVILAS) Fluorescein Angiography for Diabetic Macular Edema. Chalam KV; Murthy RK; Brar V; Radhakrishnan R; Khetpal V; Grover S Middle East Afr J Ophthalmol; 2012 Jan; 19(1):158-62. PubMed ID: 22346133 [TBL] [Abstract][Full Text] [Related]
18. Using Patient-Level Data to Develop Meaningful Cross-Trial Comparisons of Visual Impairment in Individuals with Diabetic Macular Edema. Sivaprasad S; Regnier SA; Fajnkuchen F; Wright J; Berger AR; Mitchell P; Larsen M Adv Ther; 2016 Apr; 33(4):597-609. PubMed ID: 26951552 [TBL] [Abstract][Full Text] [Related]
19. [Choice of treatment for diabetic macular edema]. Yang L; Zhang J Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):724-728. PubMed ID: 29050184 [TBL] [Abstract][Full Text] [Related]